Literature DB >> 26980458

Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition.

S Epstein1, G Defeudis2,3, S Manfrini4, N Napoli4, P Pozzilli4.   

Abstract

Diabetes and osteoporosis are rapidly growing diseases. The link between the high fracture incidence in diabetes as compared with the non-diabetic state has recently been recognized. While this review cannot cover every aspect of diabetic osteodystrophy, it attempts to incorporate current information from the First International Symposium on Diabetes and Bone presentations in Rome in 2014. Diabetes and osteoporosis are fast-growing diseases in the western world and are becoming a major problem in the emerging economic nations. Aging of populations worldwide will be responsible for an increased risk in the incidence of osteoporosis and diabetes. Furthermore, the economic burden due to complications of these diseases is enormous and will continue to increase unless public awareness of these diseases, the curbing of obesity, and cost-effective measures are instituted. The link between diabetes and fractures being more common in diabetics than non-diabetics has been widely recognized. At the same time, many questions remain regarding the underlying mechanisms for greater bone fragility in diabetic patients and the best approach to risk assessment and treatment to prevent fractures. Although it cannot cover every aspect of diabetic osteodystrophy, this review will attempt to incorporate current information particularly from the First International Symposium on Diabetes and Bone presentations in Rome in November 2014.

Entities:  

Keywords:  Bone metabolism; Diabetes; Diabetic osteodystrophy; Fractures

Mesh:

Year:  2016        PMID: 26980458     DOI: 10.1007/s00198-015-3454-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  222 in total

Review 1.  Radicals and oxidative stress in diabetes.

Authors:  I C West
Journal:  Diabet Med       Date:  2000-03       Impact factor: 4.359

Review 2.  Interleukin-6: An osteotropic factor influencing bone formation?

Authors:  Nathalie Franchimont; Sylvie Wertz; Michel Malaise
Journal:  Bone       Date:  2005-08-19       Impact factor: 4.398

3.  In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.

Authors:  Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

4.  Synthesis and evaluation of disulfide bond mimetics of amylin-(1-8) as agents to treat osteoporosis.

Authors:  Renata Kowalczyk; Paul W R Harris; Margaret A Brimble; Karen E Callon; Maureen Watson; Jillian Cornish
Journal:  Bioorg Med Chem       Date:  2012-02-20       Impact factor: 3.641

5.  Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans.

Authors:  Reiko Nakashima; Nozomu Kamei; Kiminori Yamane; Shuhei Nakanishi; Ayumu Nakashima; Nobuoki Kohno
Journal:  J Clin Endocrinol Metab       Date:  2006-08-01       Impact factor: 5.958

6.  Bone marrow fat is inversely related to cortical bone in young and old subjects.

Authors:  Tishya A L Wren; Sandra A Chung; Frederick J Dorey; Stefan Bluml; Gregor B Adams; Vicente Gilsanz
Journal:  J Clin Endocrinol Metab       Date:  2010-12-22       Impact factor: 5.958

7.  Fracture risk in diabetic elderly men: the MrOS study.

Authors:  Nicola Napoli; Elsa S Strotmeyer; Kristine E Ensrud; Deborah E Sellmeyer; Douglas C Bauer; Andrew R Hoffman; Thuy-Tien L Dam; Elizabeth Barrett-Connor; Lisa Palermo; Eric S Orwoll; Steven R Cummings; Dennis M Black; Ann V Schwartz
Journal:  Diabetologia       Date:  2014-06-09       Impact factor: 10.122

Review 8.  The role of bone marrow and visceral fat on bone metabolism.

Authors:  Yahtyng Sheu; Jane A Cauley
Journal:  Curr Osteoporos Rep       Date:  2011-06       Impact factor: 5.096

Review 9.  Bone and kidney disease: diagnostic and therapeutic implications.

Authors:  Sophie A Jamal; Sarah L West; Paul D Miller
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

Review 10.  Understanding the pathology and mechanisms of type I diabetic bone loss.

Authors:  Laura R McCabe
Journal:  J Cell Biochem       Date:  2007-12-15       Impact factor: 4.429

View more
  19 in total

Review 1.  Osteoporosis in patients with diabetes after kidney transplantation.

Authors:  Elvira O Gosmanova; Aidar R Gosmanov
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

2.  Relationship of Bone Turnover Markers with Serum Uric Acid-to-Creatinine Ratio in Men and Postmenopausal Women with Type 2 Diabetes.

Authors:  Yuling Xing; Jing Liu; Huanxin Liu; Huijuan Ma
Journal:  Diabetes Metab Syndr Obes       Date:  2022-10-19       Impact factor: 3.249

3.  Vertebral Fracture Risk in Diabetic Elderly Men: The MrOS Study.

Authors:  Nicola Napoli; Ann V Schwartz; Anne L Schafer; Eric Vittinghoff; Peggy M Cawthon; Neeta Parimi; Eric Orwoll; Elsa S Strotmeyer; Andrew R Hoffman; Elizabeth Barrett-Connor; Dennis M Black
Journal:  J Bone Miner Res       Date:  2017-12-27       Impact factor: 6.741

4.  Fracture risk in women with type II diabetes. Results from a historical cohort with fracture follow-up.

Authors:  Jakob Præst Holm; Thomas Jensen; Lars Hyldstrup; Jens-Erik Beck Jensen
Journal:  Endocrine       Date:  2018-02-16       Impact factor: 3.633

5.  Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials.

Authors:  Y S Zhang; W Y Weng; B C Xie; Y Meng; Y H Hao; Y M Liang; Z K Zhou
Journal:  Osteoporos Int       Date:  2018-08-06       Impact factor: 4.507

6.  Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study.

Authors:  Catherine Rousseau; Sonia Jean; Philippe Gamache; Stéfane Lebel; Fabrice Mac-Way; Laurent Biertho; Laëtitia Michou; Claudia Gagnon
Journal:  BMJ       Date:  2016-07-27

Review 7.  Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences.

Authors:  Giuseppina T Russo; Annalisa Giandalia; Elisabetta L Romeo; Morabito Nunziata; Marco Muscianisi; Maria Concetta Ruffo; Antonino Catalano; Domenico Cucinotta
Journal:  Int J Endocrinol       Date:  2016-12-04       Impact factor: 3.257

Review 8.  Diabetic Osteoporosis: A Review of Its Traditional Chinese Medicinal Use and Clinical and Preclinical Research.

Authors:  Rufeng Ma; Ruyuan Zhu; Lili Wang; Yubo Guo; Chenyue Liu; Haixia Liu; Fengwei Liu; Hongjun Li; Yu Li; Min Fu; Dongwei Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-06       Impact factor: 2.629

Review 9.  The impact of type 2 diabetes on bone metabolism.

Authors:  Claudia Pinheiro Sanches; Andre Gustavo Daher Vianna; Fellype de Carvalho Barreto
Journal:  Diabetol Metab Syndr       Date:  2017-10-19       Impact factor: 3.320

10.  Delivery of antagomiR204-conjugated gold nanoparticles from PLGA sheets and its implication in promoting osseointegration of titanium implant in type 2 diabetes mellitus.

Authors:  Xiangwei Liu; Naiwen Tan; Hongbo Wei; Yuchao Zhou; Shuai Ren; Fan Yu; Hui Chen; Chengming Jia; Guodong Yang; Yingliang Song
Journal:  Int J Nanomedicine       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.